For Immediate Release

St. Louis, Mo. (June 13, 2012) - Biomedical Systems, a global provider of centralized diagnostic services, recently expanded its clinical trials division by adding Ballwin resident Kevin Juenger as business development director. Juenger represents one of five new Biomedical directors charged with managing growing business territories in North America and Asia.

“Our new directors will expand Biomedical’s presence, helping us to grow our market share by providing clients with access to highly skilled individuals who offer industry expertise and our shared commitment to client service,” said Eliana Burke, area manager of the U.S. West and Asia Pacific Rim. 

Based in St. Louis, Juenger is responsible for business development in Tennessee, Texas and parts of the Midwest. He comes to Biomedical Systems with more than 16 years of pharmaceutical sales experience.  Prior to joining Biomedical Systems, Juenger worked as a senior oncology consultant in the biotech industry.  

About Biomedical Systems

Biomedical Systems is a global provider of centralized diagnostic services for the pharmaceutical, biopharmaceutical and medical device industries. With offices in North America, Europe and Asia, Biomedical Systems works with over 14,000 investigative sites in 95 countries for Phase I – IV clinical trials. Biomedical Systems centralized services include the acquisition, analysis and management of data for Digital Pathology, Cardiac Safety, Imaging and Pulmonary Function and Neurophysiology used to determine safety and efficacy for drugs and devices in clinical trials.